 HASBROUCK HEIGHTS, N.J., Sept. 10, 2021 GLOBE NEWSWIRE -- Nymox Pharmaceutical Corporation NASDAQ: NYMX the Company is pleased to provide an update on the Companys progress with its BPH treatment product Fexapotide Triflutate. 